A Phase IV, Randomized, factorial assigned, Open labelled, study to evaluate the non- interference in immune response of Typhoid Vi Capsular Polysaccharide - Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) administered to children at 9 months, to measles vaccine given concomitantly

Trial Profile

A Phase IV, Randomized, factorial assigned, Open labelled, study to evaluate the non- interference in immune response of Typhoid Vi Capsular Polysaccharide - Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) administered to children at 9 months, to measles vaccine given concomitantly

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Typhoid vaccine Vi conjugate (Primary) ; Measles virus vaccine live
  • Indications Typhoid
  • Focus Therapeutic Use
  • Sponsors Bharat Biotech
  • Most Recent Events

    • 29 Aug 2016 Status changed from recruiting to completed.
    • 13 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top